Article info

Download PDFPDF
905 Using chemotherapy response by KELIM score in patient with BRCA-mutated high-grade serous ovarian cancer to predict response to first line olaparib maintenance therapy: an one institution experience

Authors

Citation

Katic K, Matkovic V, Lešin J, et al
905 Using chemotherapy response by KELIM score in patient with BRCA-mutated high-grade serous ovarian cancer to predict response to first line olaparib maintenance therapy: an one institution experience

Publication history

  • First published March 10, 2024.
Online issue publication 
March 13, 2024

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.